Acyclovir prophylaxis and fever during remission-induction therapy of patients with acute myeloid leukemia: A randomized, double-blind, placebo- controlled trial

Journal of Clinical Oncology

Volumn 15, Issue 6, 1997, Pages 2269-2274

  Bergmann, Olav J ^a   Mogensen, Søren C ^a   Ellermann Eriksen, Svend ^a   Ellegaard, Jørgen ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYTARABINE; PLACEBO;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACTEREMIA; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGRESSION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FEVER; GRAM POSITIVE BACTERIUM; HERPES SIMPLEX VIRUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030912401     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.6.2269     Document Type: Article

References (19)

1. Schimpff SC: Infection in the neutropenic patient: Directions for future research. Supp Care Cancer 1:223-227, 1993
2. Guiot HFL, Peters WG, van den Broek PJ, et al: Respiratory failure elicited by streptococcal septicemia in patients treated with cytosine arabinoside, and its prevention by penicillin. Infection 18:131-137, 1990
3. Kern W, Kurrle E, Schmeiser T: Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases. Infection 18:138-145, 1990
4. Elting LS, Bodey GP, Keefe BH: Septicemia and shock syndrome due to viridans streptococci: A case control study of predisposing factors. Clin Infect Dis 14:1201-1207, 1992
5. Bochud P-Y, Eggiman PH, Calandra TH, et al: Bacteremia due to viridans streptococci in neutropenic patients with cancer: Clinical spectrum and risk factors. Clin Infect Dis 18:25-31, 1994
6. Bergmann OJ: Oral infections and fever in immunocompromised patients with haematologic malignancies. Eur J Clin Microbiol Infect Dis 8:207-213, 1989
7. Bergmann OJ, Ellermann-Eriksen S, Mogensen SC, et al: Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: Randomised, double blind, placebo controlled trial. Br Med J 310:1169-1172, 1995
8. Baglin TP, Gray JJ, Marcus RE, et al: Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy. J Clin Pathol 42:1255-1258, 1989
9. Hann IM, Prentice HG, Blacklock HA, et al: Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: Randomised double blind trial. Br Med J 287:384-387, 1983
10. Wade JC, Newton B, Flournoy N, et al: Oral acyclovir for prevention of herpes simplex reactivation after bone marrow transplantation. Ann Intern Med 100:823-828, 1984
11. Lönnquist B, Palmblad J, Ljungman P, et al: Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. Supp Care Cancer 1:139-144, 1993
12. EORTC International Antimicrobial Therapy Cooperative Group: Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 137:14-29, 1978
13. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
15. Siegel S, Castellan NJ Jr: Nonparametric Statistics for the Behavioral Sciences (ed 2). New York, NY, McGraw-Hill, 1988
16. Morris JA, Gardner MJ: Calculating confidence intervals for relative risks (odd ratios) and standardised ratios and rates. Br Med J 296:1313-1316, 1988
17. CPMP Working Party on Efficacy of Medical Products: Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products. Stat Med 14:1659-1682, 1995
18. Hughes WT, Armstrong D, Bodey GP, et al: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 161:381-396, 1990
19. Bergmann OJ: Oral infections and septicemia in immunocompromised patients with haematologic malignancies. J Clin Microbiol 26:2105-2109, 1988